Skip to main content
. 2022 Dec 1;11(12):2383. doi: 10.3390/antiox11122383

Figure 6.

Figure 6

Cy treatment enhanced hepatic Nrf2 and inhibited the NF-κB pathway. mRNA level changes in (A) HO-1, (B) NQO-1, (C) Nrf2, (D) Keap1, (E) NF-κB/p65, (F) TNF-α, (G) iNOS, and (H) COX-2, and (I) western blot analysis of protein expression (Nrf2, p65 and p-p65). * p < 0.05 and ** p < 0.01 compared with the MC group.